Evaluating the atherosclerosis cardiovascular disease risk score in patients with brain metastases: Associations with overall survival and high-value care outcomes.
Foad KazemiJiaqi LiuMegan ParkerJoshua RobinaughA Karim AhmedJordina Rincon-TorroellaChristopher JacksonGary L GalliaChetan BettegowdaJon WeingartHenry BremDebraj MukherjeePublished in: Clinical neurology and neurosurgery (2024)
This study indicates higher ASCVD risk scores in BM patients are associated with worse overall survival. Integrating ASCVD assessment into clinical workflow may facilitate more informed risk-based decision-making.
Keyphrases
- chronic kidney disease
- end stage renal disease
- cardiovascular disease
- brain metastases
- decision making
- small cell lung cancer
- healthcare
- type diabetes
- palliative care
- free survival
- ejection fraction
- quality improvement
- coronary artery disease
- electronic health record
- newly diagnosed
- prognostic factors
- peritoneal dialysis
- cardiovascular events
- breast cancer risk
- patient reported outcomes
- glycemic control